

Advanced LED phototherapy unit designed for safe and efficient treatment of neonatal jaundice. Features adjustable intensity, digital timer, and silent operation—ideal for NICUs, maternity wards, and pediatric care.
Guaranteed safe checkout




Monday - Friday 9:00 - 6 :00
Description
Description
The Infant Phototherapy Unit LED BL-50D is a modern neonatal care system designed for the safe and effective treatment of newborn jaundice. Using advanced blue LED technology, it provides consistent and high-intensity light to reduce bilirubin levels efficiently while maintaining infant comfort and safety.
Ideal for use in NICUs, maternity wards, and pediatric units, the BL-50D features adjustable light intensity, height, and angle settings to accommodate various treatment needs and infant positions. Its digital timer, quiet operation, and energy-efficient design make it an essential tool for reliable and long-lasting phototherapy care.
Engineered for precision and ease of use, this unit ensures uniform light distribution, minimal heat emission, and superior performance, giving healthcare professionals full control and confidence during neonatal jaundice management.
🔸 Key Features
-
High-intensity blue LED light for rapid bilirubin breakdown
-
Adjustable irradiance levels (Low / Medium / High) for tailored therapy
-
Digital display with treatment time and total usage counter
-
Minimal heat generation for maximum infant comfort
-
Adjustable height and head angle for optimal positioning
-
Silent operation ideal for neonatal environments
-
Wide coverage area for effective light exposure
-
Durable, energy-efficient design with long LED lifespan
-
Mobile stand with lockable castors for easy movement between wards
Delivery Info
- Standard and Express delivery services are available for all items.
- Shipping costs are calculated at the checkout page (after delivery option & destination confirmation).
- Tracking is available for all delivery options.
- Items are delivered during standard business hours.
Reviews
There are no reviews yet.